Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wadden

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|May 5, 2009
When prevention fails: obesity treatment strategiesLouis J Aronne, Thomas Wadden, Kathy Keenan Isoldi, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysisRobert F Kushner, Anders Fink-Jensen, Ofir Frenkel, et al.
Diabetes Care|June 28, 2002
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metforminJohn M Miles, Lawrence Leiter, Priscilla Hollander, et al.
JAMA|March 9, 2016
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical TrialSteven E Nissen, Kathy E Wolski, Lisa Prcela, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trialsDomenica Rubino, Jakob B Bjorner, Naveen Rathor, et al.
Diabetes Care|June 9, 2016
Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical TrialRena R Wing, Mark A Espeland, Jeanne M Clark, et al.
Journal of Behavioral Medicine|June 23, 2017
Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathwaysDiana A Chirinos, Indira Gurubhagavatula, Preston Broderick, et al.
Psychoneuroendocrinology|September 30, 2016
Relative differences in resting-state brain connectivity associated with long term intensive lifestyle interventionRamon Casanova, Satoru Hayasaka, Santiago Saldana, et al.
Diabetes Care|June 13, 2013
Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD studyRena R Wing, Dale S Bond, Isaias Noel Gendrano, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|May 5, 2009
When prevention fails: obesity treatment strategiesLouis J Aronne, Thomas Wadden, Kathy Keenan Isoldi, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysisRobert F Kushner, Anders Fink-Jensen, Ofir Frenkel, et al.
Diabetes Care|June 28, 2002
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metforminJohn M Miles, Lawrence Leiter, Priscilla Hollander, et al.
JAMA|March 9, 2016
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical TrialSteven E Nissen, Kathy E Wolski, Lisa Prcela, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trialsDomenica Rubino, Jakob B Bjorner, Naveen Rathor, et al.
Diabetes Care|June 9, 2016
Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical TrialRena R Wing, Mark A Espeland, Jeanne M Clark, et al.
Journal of Behavioral Medicine|June 23, 2017
Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathwaysDiana A Chirinos, Indira Gurubhagavatula, Preston Broderick, et al.
Psychoneuroendocrinology|September 30, 2016
Relative differences in resting-state brain connectivity associated with long term intensive lifestyle interventionRamon Casanova, Satoru Hayasaka, Santiago Saldana, et al.
Diabetes Care|June 13, 2013
Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD studyRena R Wing, Dale S Bond, Isaias Noel Gendrano, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
Pageof 2